Current therapies for cardiac allograft vasculopathy in children

Medicine and Dentistry

• Cardiac Allograft Vasculopathy 80%
• Child 40%
• Combination Therapy 30%
• Diagnosis 20%
• Graft Failure 20%
• Adult 20%
• Diseases 10%
• Transplantation 10%
• Prevalence 10%
• Complication 10%
• Stimulus 10%
• Development 10%
• Surveillance 10%
• Serositis 10%
• Immunosuppressive Drug 10%
• Infection 10%
• Heart Transplantation 10%
• Heart Graft 10%
• Injury 10%
• Graft Survival 10%
• Endothelial Dysfunction 10%
• Chronic Graft Rejection 10%
• Retransplantation 10%
• Heart Disease 10%
• Mortality 10%
• Patient 10%
• Pediatrics 10%
• Comprehension 10%
• Randomized Controlled Trial 10%
• Medication 10%
• Death 10%

INIS

• children 40%
• grafts 40%
• therapy 30%
• risks 20%
• adults 20%
• losses 20%
• data 10%
• patients 10%
• interactions 10%
• pediatrics 10%
• transplants 10%
• diseases 10%
• management 10%
• interventions 10%
• mortality 10%
• inflammation 10%
• stimuli 10%
• death 10%
• heart disease 10%
• injuries 10%
• surveillance 10%

Immunology and Microbiology

• Allograft Vasculopathy 100%
• Transplantation 20%
• Heart 20%
• Data Base 10%
• Prevalence 10%
• Chronic Graft Rejection 10%
• Development 10%
• Mortality 10%
• Survival 10%
• Comprehension 10%
• Inflammation 10%
• Immunity 10%
• Heart Transplantation 10%